Related Experiment Videos
Putting drug abuse research to use in real-life settings
Glen R Hanson1, Alan I Leshner, Betty Tai
1National Institute on Drug Abuse, 6001 Executive Boulevard, Room 4123, Bethesda, MD 20892, USA.
Journal of Substance Abuse Treatment
|September 11, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Methcathinone self-administration decreases dopamine and serotonin transporter function in rats.
Drug and alcohol dependence·2026
Differential Effects of Neurotensin NTS1 and NTS2 Receptors on Locomotion.
Brain and behavior·2025
Unburden American science.
Science (New York, N.Y.)·2025
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus.
Addiction science & clinical practice·2024
Methcathinone decreases dopamine transporter function: Role of protein kinase C.
Journal of neurochemistry·2021
A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.
Journal of substance abuse treatment·2022
Factors associated with the adoption of evidence-based innovations by substance use disorder treatment organizations: A study of HIV testing.
Journal of substance abuse treatment·2022
An intervention pilot to facilitate harm reduction service decentralization in Vietnam.
Journal of substance abuse treatment·2022
Housing and supportive services for substance use and self-efficacy among young mothers experiencing homelessness: A randomized controlled trial.
Journal of substance abuse treatment·2022
Digital interventions for opioid use disorder treatment: A systematic review of randomized controlled trials.
Journal of substance abuse treatment·2022
Multi-database pharmacovigilance identifies disproportionate reporting of hepatobiliary events with avacopan: an integrative study with network pharmacology and interpretable machine learning.
Naunyn-Schmiedeberg's archives of pharmacology·2026
AI-Guided Discovery of Natural-Product-Inspired Scaffolds as Dual P-gp/BCRP Inhibitors to Overcome Cancer Multidrug Resistance.
Journal of medicinal chemistry·2026
Real-world outcomes of sitagliptin and sitagliptin/metformin single-pill combination treatment in diverse type 2 diabetes populations (DIVERSITY study).
Frontiers in clinical diabetes and healthcare·2026
Polypharmacy status and its related risk factors among elderly patients with dyslipidemia: Iranian multi-center osteoporosis study (IMOS) 2021.
Journal of diabetes and metabolic disorders·2026